Tudor Investment Corp Et Al Reduces Holdings in Relx Plc (NYSE:RELX)

Tudor Investment Corp Et Al lessened its holdings in Relx Plc (NYSE:RELX – Get Rating) by 59.4% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 25,800 shares of the technology company’s stock after selling 37,686 shares during the period. Tudor Investment Corp Et Al’s holdings in Relx were worth $627,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of RELX. CoreCap Advisors LLC acquired a new position in shares of Relx in the second quarter worth $28,000. Allworth Financial LP raised its stake in Relx by 455.3% in the 3rd quarter. Allworth Financial LP now owns 1,455 shares of the technology company’s stock valued at $35,000 after purchasing an additional 1,193 shares during the last quarter. Pinnacle Bancorp Inc. purchased a new position in Relx in the 3rd quarter valued at about $35,000. Penserra Capital Management LLC acquired a new stake in shares of Relx during the 3rd quarter worth about $36,000. Finally, Wipfli Financial Advisors LLC purchased a new stake in shares of Relx during the third quarter worth about $42,000. 3.41% of the stock is currently owned by institutional investors and hedge funds.

Relx Stock Performance

Shares of Relx stock opened at $30.72 on Monday. The company has a current ratio of 0.59, a quick ratio of 0.53 and a debt-to-equity ratio of 1.56. The business’s fifty day moving average price is $29.25 and its 200 day moving average price is $27.51. Relx Plc has a twelve month low of $23.39 and a twelve month high of $32.24.

Relx Increases Dividend

The company also recently disclosed a Semi-Annual dividend, which will be paid on Monday, June 12th. Stockholders of record on Friday, April 28th will be paid a $0.466 dividend. This is a positive change from Relx’s previous Semi-Annual dividend of $0.44. The ex-dividend date of this dividend is Thursday, April 27th.

Analyst Ratings Changes

RELX has been the topic of several recent analyst reports. Morgan Stanley reduced their price objective on shares of Relx from GBX 3,020 ($36.44) to GBX 2,950 ($35.60) in a research note on Friday, December 16th. Barclays cut Relx from an “overweight” rating to an “equal weight” rating in a report on Tuesday, January 31st. StockNews.com started coverage on Relx in a research report on Wednesday, November 30th. They set a “hold” rating on the stock. Credit Suisse Group raised their price target on Relx from GBX 2,800 ($33.79) to GBX 2,860 ($34.51) in a research note on Friday, February 17th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Relx from GBX 2,730 ($32.94) to GBX 2,810 ($33.91) in a report on Thursday, January 26th.

Relx Company Profile

(Get Rating)

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.